The tariff classification of Mircera (methoxy polyethylene glycol-epoetin beta) in dosage form, from Switzerland
Issued October 15, 2015 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3002.10.0290
Headings: 3002
Product description
The subject product Mircera, is a medicinal preparation containing methoxy polyethylene glycol-epoetin beta, a chemically modified erythropoiesis stimulating agent (ESA), as the active ingredient. It is indicated for the treatment of anemia associated with chronic kidney disease. Mircera will be imported in pre-filled syringes in various doses ranging from 50 to 250 mcg/0.30mL.
CBP rationale
The applicable subheading for Mircera (methoxy polyethylene glycol-epoetin beta), imported in dosage form, will be 3002.10.0290, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Antisera, other blood fractions and immunological products, whether or not obtained by means of biotechnological processes: Other.
Full text
N269182 October 15, 2015 CLA-2-30:OT:RR:NC:2:238 CATEGORY: Classification TARIFF NO.: 3002.10.0290 Mr. Stephen S. Spraitzar Tuttle Law Offices 100 Larkspur Landing Circle, Suite 385 Larkspur, CA 94939 RE: The tariff classification of Mircera (methoxy polyethylene glycol-epoetin beta) in dosage form, from Switzerland Dear Mr. Spraitzar: In your letter dated September, 22, 2015 on behalf of Fresenius Medical Services Group, LLC dba Fresenius Medical Care North America, you requested a tariff classification ruling. The subject product Mircera, is a medicinal preparation containing methoxy polyethylene glycol-epoetin beta, a chemically modified erythropoiesis stimulating agent (ESA), as the active ingredient. It is indicated for the treatment of anemia associated with chronic kidney disease. Mircera will be imported in pre-filled syringes in various doses ranging from 50 to 250 mcg/0.30mL. The applicable subheading for Mircera (methoxy polyethylene glycol-epoetin beta), imported in dosage form, will be 3002.10.0290, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Antisera, other blood fractions and immunological products, whether or not obtained by means of biotechnological processes: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Gwenn Klein Kirschner Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of rFVIII Membrane Adsorber Eluate Formulated (MAEF) and KOVALTRY®
The tariff classification of Anti-Actin antibody [EPR16769] ab179467, from China
The tariff classification of Anti-beta Actin antibody [mAbcam 8226], from the United States
The tariff classification of a rabbit polyclonal antibody from United Kingdom
The tariff classification of Anti-GFP antibody (ab6556) from Canada
The tariff classification of Hemo bioscience HBS- C3 Control Cells. No country of origin was provided.
The tariff classification of Betaseron® (interferon beta-1b) injectable in dosage form, from Germany. Correction to Ruling Number N242939
The tariff classification of Aflibercept (CAS-862111-32-8) and EYLEA® Injection from Germany
The tariff classification of Calbiochem® Apolipoprotein A-I Human Plasma, High-Density Lipoprotein from the United States
The tariff classification of MaxSignal® Trifluralin ELISA Test Kit
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →